Antiretroviral prescribing patterns in the texas prison system

Jacques Baillargeon, Michael J. Borucki, Stephanie Zepeda, Hal B. Jenson, Charles T. Leach

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Although the prevalence of human immunodeficiency virus (HIV) infection among prison inmates is reported to be high, little is known about anti-HIV treatment patterns in correctional institutions. The present study assessed antiretroviral prescribing patterns for 2360 Texas Department of Criminal Justice (TDCJ) inmates infected with HIV. In 1998, 66.8% of all TDCJ inmates infected with HIV who had CD4 lymphocyte counts <500 cells/mm3 were treated with highly active antiretroviral therapy (HAART). However, no substantial differences in the use of HAART were exhibited according to the sociodemographic factors under study. While the majority of inmates receiving HAART in 1998 were prescribed a combination of 2 nucleoside reverse transcriptase inhibitors (NRTIs) and 1 protease inhibitor, 11.2% were prescribed a combination of 2 NRTIs and 1 non-NRTI. In view of the elevated rate of HIV infection in correctional settings, it will be important to continue to document the pharmacotherapy patterns among prison inmates, both during and following incarceration.

Original languageEnglish (US)
Pages (from-to)1476-1481
Number of pages6
JournalClinical Infectious Diseases
Volume31
Issue number6
StatePublished - 2000
Externally publishedYes

Fingerprint

Prisons
HIV
Reverse Transcriptase Inhibitors
Highly Active Antiretroviral Therapy
Criminal Law
Virus Diseases
Nucleosides
CD4 Lymphocyte Count
Protease Inhibitors
Drug Therapy

ASJC Scopus subject areas

  • Immunology

Cite this

Baillargeon, J., Borucki, M. J., Zepeda, S., Jenson, H. B., & Leach, C. T. (2000). Antiretroviral prescribing patterns in the texas prison system. Clinical Infectious Diseases, 31(6), 1476-1481.

Antiretroviral prescribing patterns in the texas prison system. / Baillargeon, Jacques; Borucki, Michael J.; Zepeda, Stephanie; Jenson, Hal B.; Leach, Charles T.

In: Clinical Infectious Diseases, Vol. 31, No. 6, 2000, p. 1476-1481.

Research output: Contribution to journalArticle

Baillargeon, J, Borucki, MJ, Zepeda, S, Jenson, HB & Leach, CT 2000, 'Antiretroviral prescribing patterns in the texas prison system', Clinical Infectious Diseases, vol. 31, no. 6, pp. 1476-1481.
Baillargeon J, Borucki MJ, Zepeda S, Jenson HB, Leach CT. Antiretroviral prescribing patterns in the texas prison system. Clinical Infectious Diseases. 2000;31(6):1476-1481.
Baillargeon, Jacques ; Borucki, Michael J. ; Zepeda, Stephanie ; Jenson, Hal B. ; Leach, Charles T. / Antiretroviral prescribing patterns in the texas prison system. In: Clinical Infectious Diseases. 2000 ; Vol. 31, No. 6. pp. 1476-1481.
@article{9bed3f8197834a03a2868a0ed0ca3b2f,
title = "Antiretroviral prescribing patterns in the texas prison system",
abstract = "Although the prevalence of human immunodeficiency virus (HIV) infection among prison inmates is reported to be high, little is known about anti-HIV treatment patterns in correctional institutions. The present study assessed antiretroviral prescribing patterns for 2360 Texas Department of Criminal Justice (TDCJ) inmates infected with HIV. In 1998, 66.8{\%} of all TDCJ inmates infected with HIV who had CD4 lymphocyte counts <500 cells/mm3 were treated with highly active antiretroviral therapy (HAART). However, no substantial differences in the use of HAART were exhibited according to the sociodemographic factors under study. While the majority of inmates receiving HAART in 1998 were prescribed a combination of 2 nucleoside reverse transcriptase inhibitors (NRTIs) and 1 protease inhibitor, 11.2{\%} were prescribed a combination of 2 NRTIs and 1 non-NRTI. In view of the elevated rate of HIV infection in correctional settings, it will be important to continue to document the pharmacotherapy patterns among prison inmates, both during and following incarceration.",
author = "Jacques Baillargeon and Borucki, {Michael J.} and Stephanie Zepeda and Jenson, {Hal B.} and Leach, {Charles T.}",
year = "2000",
language = "English (US)",
volume = "31",
pages = "1476--1481",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Antiretroviral prescribing patterns in the texas prison system

AU - Baillargeon, Jacques

AU - Borucki, Michael J.

AU - Zepeda, Stephanie

AU - Jenson, Hal B.

AU - Leach, Charles T.

PY - 2000

Y1 - 2000

N2 - Although the prevalence of human immunodeficiency virus (HIV) infection among prison inmates is reported to be high, little is known about anti-HIV treatment patterns in correctional institutions. The present study assessed antiretroviral prescribing patterns for 2360 Texas Department of Criminal Justice (TDCJ) inmates infected with HIV. In 1998, 66.8% of all TDCJ inmates infected with HIV who had CD4 lymphocyte counts <500 cells/mm3 were treated with highly active antiretroviral therapy (HAART). However, no substantial differences in the use of HAART were exhibited according to the sociodemographic factors under study. While the majority of inmates receiving HAART in 1998 were prescribed a combination of 2 nucleoside reverse transcriptase inhibitors (NRTIs) and 1 protease inhibitor, 11.2% were prescribed a combination of 2 NRTIs and 1 non-NRTI. In view of the elevated rate of HIV infection in correctional settings, it will be important to continue to document the pharmacotherapy patterns among prison inmates, both during and following incarceration.

AB - Although the prevalence of human immunodeficiency virus (HIV) infection among prison inmates is reported to be high, little is known about anti-HIV treatment patterns in correctional institutions. The present study assessed antiretroviral prescribing patterns for 2360 Texas Department of Criminal Justice (TDCJ) inmates infected with HIV. In 1998, 66.8% of all TDCJ inmates infected with HIV who had CD4 lymphocyte counts <500 cells/mm3 were treated with highly active antiretroviral therapy (HAART). However, no substantial differences in the use of HAART were exhibited according to the sociodemographic factors under study. While the majority of inmates receiving HAART in 1998 were prescribed a combination of 2 nucleoside reverse transcriptase inhibitors (NRTIs) and 1 protease inhibitor, 11.2% were prescribed a combination of 2 NRTIs and 1 non-NRTI. In view of the elevated rate of HIV infection in correctional settings, it will be important to continue to document the pharmacotherapy patterns among prison inmates, both during and following incarceration.

UR - http://www.scopus.com/inward/record.url?scp=0034567538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034567538&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 1476

EP - 1481

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -